CERS2

Across TCGA pan-cancer cohorts, CERS2 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of CERS2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where CERS2 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types CERS2 is over-expressed in tumor.

COAD, LUAD, and HNSC are the cancer types where CERS2 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CERS2 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.625	<.001	10	view →
LUAD	Female	III,IV	+0.642	<.001	8	view →
HNSC	Male	IV	+0.638	<.001	8	view →
PDAC	All	IV	+0.703	.020	2	view →
OV	All	All	+0.338	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

CERS2–COAD

Open the COAD breakdown →